2023 Cancer Vaccine Landscape Review

The cancer vaccine industry is growing rapidly, especially with the rise of viral vaccines by 50% since 2022. The market is becoming saturated, so it’s crucial to choose the best candidates for preclinical testing to avoid competition and make informed investments based on data. Our Cancer Vaccine team has created a comprehensive review of the 2023 landscape, examining the challenges that developers have faced and are likely to face in the upcoming years.

You can access your copy of the report for an in-depth analysis of the current situation, a summary of regulatory announcements made in 2023, and valuable insights into the future of the cancer vaccine space.

Download Here

Delve into the 2023 Cancer Vaccine Landscape

A comprehensive analysis of the drugs, trials, deals, and companies’ landscapes for the Cancer Vaccine space and regulatory announcements from 2023.

Download Here

About the 2023 Landscape Review

The cancer vaccine space is predominantly clinical, with 58% of assets either being currently clinically active, or having been clinically active at some point in their development. Among all the therapeutic classes of cancer vaccines, viral vaccines are the fastest, followed closely by nucleic acid-based vaccines. As of January 2024, 24 trials are expected to begin, and 145 trials are anticipated to end.

Nucleic acid-based vaccines were the second-fastest-growing therapeutic class in the cancer vaccine sector in 2023, accounting for 36% of new drugs. Our latest data expansion has added exclusive deals and companies’ insights, providing an unrivaled understanding of the commercial market and the future of the space.

If you want to get these details and more, you can download the 2023 Cancer Vaccine Landscape report.

Find out more

Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

Each dataset features proprietary, hyper-relevant search and filtering tailored to specific modalities, in-depth data, plus additional market insight curated by our subject matter experts. Beacon is here to support you in making these decisions with confidence through our encompassing database solution.